Increased survivorship and altered cytokine profile from treatment of influenza A H1N1-infected mice with ekybion: A drug complex of natural extracts and inorganic compounds

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Pastey, Manoj ^b   Lupfer, Christopher ^a,b   Besnouin, Didier ^c   Tepper, Samuel E ^b   Maselko, MacIej ^b   Patton, Kristin M ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c DVM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CALCIUM HYDRATE; CALCIUM PHOSPHATE; CALCIUM SULFIDE; CEDAR LEAF OIL; EKYBION; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INORGANIC COMPOUND; INTERLEUKIN 6; IODINE; NITRIC ACID; PHOSPHORUS; POTASSIUM BISULPHATE; SILICIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARNICA MONTANA; ARTICLE; BAGG ALBINO MOUSE; BAPTISIA TINCTORIA; BRYONIA; BRYONIA ALBA; COMPARATIVE STUDY; CONTROLLED STUDY; CUTTLEFISH; CYTOKINE PRODUCTION; DRUG EFFICACY; ECHINACEA; ECHINACEA ANGUSTIFOLIA; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETHAL DOSE; LYTTA VESICATORIA; MEDICINAL PLANT; MOUSE; NONHUMAN; PHELLANDRIUM AQUATICUM; PRIORITY JOURNAL; PULSATILLA; PULSATILLA NIGRICANS; SURVIVAL RATE; SURVIVOR; THUJA; WEIGHT REDUCTION;

EID: 78349241119     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/192079     Document Type: Article

References (44)

1. McCullers J. A., Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza Journal of Infectious Diseases 2004 190 3 519 526
2. Martella V., Elia G., Decaro N., Di Trani L., Lorusso E., Campolo M., Desario C., Parisi A., Cavaliere N., Buonavoglia C., An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage Veterinary Microbiology 2007 121 1-2 56 63
3. Yoon K.-J., Cooper V. L., Schwartz K. J., Harmon K. M., Kim W.-I., Janke B. H., Strohbehn J., Butts D., Troutman J., Influenza virus infection in racing greyhounds Emerging Infectious Diseases 2005 11 12 1974 1976
4. Chutinimitkul S., Songserm T., Amonsin A., Payungporn S., Suwannakarn K., Damrongwatanapokin S., Chaisingh A., Nuansrichay B., Chieochansin T., Theamboonlers A., Poovorawan Y., New strain of influenza A virus (H5N1), Thailand Emerging Infectious Diseases 2007 13 3 506 507
5. Nicholls J. M., Chan M. C. W., Chan W. Y., Wong H. K., Cheung C. Y., Kwong D. L. W., Wong M. P., Chui W. H., Poon L. L. M., Tsao S. W., Guan Y., Peiris J. S. M., Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract Nature Medicine 2007 13 2 147 149
6. WHO. Confirmed human cases of avain influenza A (H5N1), http://www.who.int/csr/disease/avianinfluenza/country/casestable20090522/en/ index.html
7. Crawford P. C., Dubovi E. J., Castleman W. L., Stephenson I., Gibbs E. P. J., Chen L., Smith C., Hill R. C., Ferro P., Pompey J., Bright R. A., Medina M.-J., Johnson C. M., Olsen C. W., Cox N. J., Klimov A. I., Katz J. M., Donis R. O., Epidemiology: transmission of equine influenza virus to dogs Science 2005 310 5747 482 485
8. WHO. Pandemic (H1N1) 2009, http://www.who.int/csr/don/20100319/en/index. html
9. WHO. Acute Respiratory Infections, http://www.who.int/vaccineresearch/ diseases/ari/en/index.html
10. Sharma M., Anderson S. A., Schoop R., Hudson J. B., Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract Antiviral Research 2009 83 2 165 170
11. Cillniz C., Shinya K., Peng X., Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes PLoS pathogens 2009 5 10
12. Kash J. C., Tumpey T. M., Proll S. C., Carter V., Perwitasari O., Thomas M. J., Basler C. F., Palese P., Taubenberger J. K., Garca-Sastre A., Swayne D. E., Katze M. G., Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus Nature 2006 443 7111 578 581
13. Peschke T., Bender A., Nain M., Gemsa D., Role of macrophage cytokines in influenza A virus infections Immunobiology 1993 189 3-4 340 355
14. Gentile D., Doyle W., Whiteside T., Fireman P., Hayden F. G., Skoner D., Increased interleukin-6 levels in nasal lavage samples following experimental influenza a virus infection Clinical and Diagnostic Laboratory Immunology 1998 5 5 604 608
15. Bonville C. A., Rosenberg H. F., Domachowske J. B., Macrophage inflammatory protein-1 and RANTES are present in nasal secretions during ongoing upper respiratory tract infection Pediatric Allergy and Immunology 1999 10 1 39 44
16. Kallas E. G., Reynolds K., Andrews J., Treanor J. J., Evans T. G., Production of influenza-stimulated tumor necrosis factor- by monocytes following acute influenza infection in humans Journal of Interferon and Cytokine Research 1999 19 7 751 755
17. Kaiser L., Fritz R. S., Straus S. E., Gubareva L., Hayden F. G., Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses Journal of Medical Virology 2001 64 3 262 268
18. Oh J.-W., Lee H.-B., Park I.-K., Kang J.-O., Interleukin-6, interleukin-8, interleukin-11, and interferon- levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection Pediatric Allergy and Immunology 2002 13 5 350 356
19. Bot A., Smith K. A., Von Herrath M., Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology DNA and Cell Biology 2004 23 6 341 350
20. Alleva L. M., Cai C., Clark I. A., Using complementary and alternative medicines to target the host response during severe influenza Evidence-Based Complementary and Alternative Medicine 2010 7 4 501 510
21. Lindequist U., Niedermeyer T. H. J., Jlich W.-D., The pharmacological potential of mushrooms Evidence-Based Complementary and Alternative Medicine 2005 2 3 285 299
22. Karkos P. D., Leong S. C., Karkos C. D., Sivaji N., Assimakopoulos D. A., Spirulina in clinical practice: evidence-based human applications. Evidence-Based Complementary and Alternative Medicine. In press
23. Firenzuoli F., Gori L., Herbal medicine today: clinical and research issues Evidence-Based Complementary and Alternative Medicine 2007 4 1 37 40
24. Rainsford K. D., Influenza (Bird Flu), inflammation and anti-inflammatory/ analgesic drugs Inflammopharmacology 2006 14 1-2 2 9
25. Chiou W.-F., Ko H.-C., Wei B.-L., Evodia rutaecarpa and three major alkaloids abrogate influenza A virus (H1N1)-induced chemokines production and cell migration.. In press. Evidence-Based Complementary and Alternative Medicine. In press
26. Chiou W.-F., Chen C.-C., Wei B.-L., 8-prenylkaempferol suppresses influenza A virus-induced RANTES production in A549 cells via blocking PI3K-mediated transcriptional activation of NF-kappaB and IRF3. Evidence-Based Complementary and Alternative Medicine. In press
27. Rajbhandari M., Mentel R., Jha P. K., Antiviral activity of some plants used in nepalese traditional medicine Evidence-Based Complementary and Alternative Medicine 2009 6 4 517 522
28. Francia F. D., Omeopatia Veterinaria 1985 Milano, Italy Red Edizioni-Boroli Editore
29. Lahoud J. A., Homeopathic Medical Matter 1998 Lyon, France Editions Boiron
30. Besnouin D., Ekybion Journal of Equine Veterinary Science 2002 22 11 485
31. Lupfer C., Stein D. A., Mourich D. V., Tepper S. E., Iversen P. L., Pastey M., Inhibition of influenza a H3N8 virus infections in mice by morpholino oligomers Archives of Virology 2008 153 5 929 937
32. Senchina D. S., McCann D. A., Asp J. M., Johnson J. A., Cunnick J. E., Kaiser M. S., Kohut M. L., Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4C for four days Clinica Chimica Acta 2005 355 1-2 67 82
33. Zhai Z., Liu Y., Wu L., Senchina D. S., Wurtele E. S., Murphy P. A., Kohut M. L., Cunnick J. E., Enhancement of innate and adaptive immune functions by multiple Echinacea species Journal of Medicinal Food 2007 10 3 423 434
34. Weremczuk-Jezyna I., Kisiel W., Wysokiska H., Thymol derivatives from hairy roots of Arnica montana Plant Cell Reports 2006 25 9 993 996
35. Widrig R., Suter A., Saller R., Melzer J., Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study Rheumatology International 2007 27 6 585 591
36. Braga P. C., Dal Sasso M., Culici M., Bianchi T., Bordoni L., Marabini L., Anti-inflammatory activity of thymol: inhibitory effect on the release of human neutrophil Elastase Pharmacology 2006 77 3 130 136 (Pubitemid 44114389)
37. Knight V., Noall M. W., Moore R., Chan E., Thymol suppression of protein synthesis in influenza virus infected and uninfected chick embryo fibroblast cells Proceedings of the Society for Experimental Biology and Medicine 1977 155 1 128 136
38. Lyss G., Knorre A., Schmidt T. J., Pahl H. L., Merfort I., The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF- B by directly targeting p65 The Journal of Biological Chemistry 1998 273 50 33508 33516
39. Mazur I., Wurzer W. J., Ehrhardt C., Pleschka S., Puthavathana P., Silberzahn T., Wolff T., Planz O., Ludwig S., Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF- B-inhibiting activity Cellular Microbiology 2007 9 7 1683 1694
40. Wurzer W. J., Ehrhardt C., Pleschka S., Berberich-Siebelt F., Wolff T., Walczak H., Planz O., Ludwig S., NF- B-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation The Journal of Biological Chemistry 2004 279 30 30931 30937
41. Wurzer W. J., Planz O., Ehrhardt C., Giner M., Silberzahn T., Pleschka S., Ludwig S., Caspase 3 activation is essential for efficient influenza virus propagation The EMBO Journal 2003 22 11 2717 2728
42. Naser B., Bodinet C., Tegtmeier M., Lindequist U., Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties Evidence-Based Complementary and Alternative Medicine 2005 2 1 69 78
43. Utsunomiya T., Kobayashi M., Pollard R. B., Suzuki F., Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus Antimicrobial Agents and Chemotherapy 1997 41 3 551 556
44. Weiss I. D., Wald O., Wald H., IFN- treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner Journal of Interferon and Cytokine Research 2010 30 6 439 449